The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer

Abstract

Distant metastasis remains the major cause of morbidity for breast cancer. Individuals with liver or brain metastasis have an extremely poor prognosis and low response rates to anti-PD-1/L1 immune checkpoint therapy compared to those with metastasis at other sites. Therefore, it is urgent to investigate the underlying mechanism of anti-PD-1/L1 resistance and develop more effective immunotherapy strategies for these patients. Using single-cell RNA sequencing, a high-resolution map of the entire tumor ecosystem based on 44 473 cells from breast cancer liver and brain metastases is depicted. Identified by canonical markers and confirmed by multiplex immunofluorescent staining, the metastatic ecosystem features remarkable reprogramming of immunosuppressive cells such as FOXP3+ regulatory T cells, LAMP3+ tolerogenic dendritic cells, CCL18+ M2-like macrophages, RGS5+ cancer-associated fibroblasts, and LGALS1+ microglial cells. In addition, PD-1 and PD-L1/2 are barely expressed in CD8+ T cells and cancer/immune/stromal cells, respectively. Interactions of the immune checkpoint molecules LAG3-LGALS3 and TIGIT-NECTIN2 between CD8+ T cells and cancer/immune/stromal cells are found to play dominant roles in the immune escape. In summary, this study dissects the intratumoral heterogeneity and immunosuppressive microenvironment in liver and brain metastases of breast cancer for the first time, providing insights into the most appropriate immunotherapy strategies for these patients.

4‐Methoxydalbergione Elicits Anticancer Effects by Upregulation of GADD45G in Human Liver Cancer Cells

“…Consequently, it is necessary to explore more efective drugs with low toxicity against HCC. Excessive proliferation, uncontrolled migration, and abnormal apoptosis are important malignant biological behaviors of tumor cells [19,20]. It is well known that several natural herbal products exhibit remarkably anticancer effects by inhibiting tumor cells proliferation, migration, and inducing apoptosis.…”

Krüppel-like factors in tumors: Key regulators and therapeutic avenues

“…As the targets and functions of KLFs continue to be investigated, small molecule inhibitors of KLFs have also been developed. ML264, as a KLF5 inhibitor, significantly attenuated the migration ability and colonization of BC cells and osteosarcoma cells in vitro experiments, suggesting a potential clinical application (226,227). Other small molecule inhibitors with similar effects to ML264 include SR18662, CID5951923, and SR15006, which have different inhibitory efficiencies against KLF5, but all have shown potential for clinical applications (60).…”

Novel roles of RNA-binding proteins in drug resistance of breast cancer: from molecular biology to targeting therapeutics

“…In addition to PD-L1, other factors could contribute to the immune-resistance of BC [95]. Metadherin, which is associated with poor prognosis of BC contributes to immunity evasion [96].…”